Eli Lilly Invests $3 Billion in Wisconsin Manufacturing Expansion to Meet Growing Demand for Diabetes and Obesity Medicines

Investment:
Eli Lilly is investing $3 billion to expand its manufacturing facility in Kenosha County, Wisconsin, to meet the growing demand for its diabetes and obesity medicines123.

Job Creation:
The expansion is expected to add 750 highly skilled jobs to the current 130-plus workforce at the location, including operators, technicians, engineers, and scientists. Additionally, it will create over 2,000 construction jobs during the project124.

Facility Details:
The expanded facility will focus on manufacturing injectable medicines, device assembly, and packaging for medicines across multiple therapeutic areas. It will use advanced automation, including guided vehicles, robotics, and production equipment, to accelerate medicine production124.

Total Investment:
The acquisition, expansion, and additional purchases of land and the adjacent warehouse bring Lilly’s total planned investment in Wisconsin to $4 billion124.

Global Context:
Since 2020, Lilly has committed more than $23 billion to construct, expand, and acquire manufacturing sites worldwide, including significant investments in Indiana and Ireland123.

Regional Impact:
The expansion is part of Wisconsin’s growth as a U.S. Regional Tech Hub in biohealth, which is expected to create over 30,000 jobs in the personalized medicine sector and over 111,000 indirect jobs in the state within the first decade24.

Sources:

1. https://www.insideindianabusiness.com/articles/lilly-to-spend-3b-to-expand-wisconsin-factory

2. https://businessfacilities.com/eli-lilly-plans-3b-manufacturing-expansion-in-wisconsin/

3. https://www.biospace.com/business/lilly-pumps-3b-into-wisconsin-site-as-compounders-close-in-on-tirzepatide

4. https://www.wispolitics.com/2024/gov-evers-with-eli-lilly-and-company-celebrate-3-billion-expansion-of-manufacturing-facility-in-wisconsin/